EVALUATION OF BIOCHEMICAL PARAMETERS IN CORONARY ARTERY PATIENTS WITH COVID-19 INFECTION

As a result of pneumonia brought on by coronavirus disease (COVID-19), acute myocardial infarction, and chronic cardiovascular system damage, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells via ACE2 receptors. In patients with coronary artery disease (CAD) who are positive for COVID-19, early measurement of cardiac damage through biomarkers and careful monitoring of myocardial damage that may be caused by infection should be performed. The goal of this study was to retrospectively assess the results of biochemical laboratory testing in patients with CAD and COVID-19. Biochemical laboratory results of 70 patients with CAD and COVID-19 and 70 patients only with CAD were examined retrospectively. A significant difference was detected between groups in terms of LDH, CRP, and Troponin I parameters. These biomarkers are important to prevent and rapidly treat COVID-related myocardial damage in patients with CAD.